AMERICAN ACADEMY OF DERMATOLOGY

Organization · DC
Hires government relations

Representative of all practicing dermatologists in United States.

Who they hire

2024 · 1 filing · Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
$██,███ / qtrUnlock

What they lobby on

Issues related to skin cancer treatment funding in FY24 MILCON/VA H.R. 4366 and S.2127and Defense appropriations H.R.4365 and S.2587.
Budget/Appropriations · 2024 Q1
Support Congressional Skin Cancer Caucus; legislative issues related to the prevention of skin cancer and cosmetic procedures, including over the counter approval of sunscreen ingredients; legislative issues related to the use of telehealth services and patient protections. Advocacy on Risk Evaluation and Mitigation Strategy (REMS) issues. Advocacy on Skin Cancer and the National Cancer Moonshot.
Health Issues · 2024 Q1
Tax on indoor tanning services.
Taxation/Internal Revenue Code · 2024 Q1
Update and reforms to Medicare payments for physicians and implementation of related provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), including regulatory relief for physicians in the MACRA Quality Payment Program, evaluation and management (E/M) codes and related legislative issues related to payment for E/M codes, and qualified clinical data registries. Maintain patient access to In-Office Ancillary Services. Issues related to adequate network coverage for dermatologic care within Medicare Advantage plans and advocate for relief from prior authorization requirements under Medicare Advantage and Medicare Part D plans. Legislative issues regarding implementation of Meaningful Use of Electronic Health Records. Medicare reimbursement for telemedicine. Medicare RAC reform and use of step therapy in Medicare and health insurance coverage including related provisions in H.R. 2630/S. 652, the Safe Step Act. Enhance Center for Medicare & Medicaid Innovation quality initiatives and patient access to Medicare Part B covered drugs, including monitor CMMI Medicare Part B drug-related demonstrations.
Medicare/Medicaid · 2024 Q1